Ergoteles’s Precigen PGEN Stock Holding History

Ergoteles’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-128,000	Closed	-$172K	–	1877
2022 Q2	$172K	Sell	128,000 -12,400	-9%	-$18.4K	0.01%	1382
2022 Q1	$296K	Buy	+140,400	New	+$342K	0.01%	843
2021 Q4	–	Sell	-40,606	Closed	-$203K	–	1513
2021 Q3	$203K	Buy	+40,606	New	+$234K	0.01%	991
2021 Q2	–	Sell	-144,290	Closed	-$994K	–	1642
2021 Q1	$994K	Buy	+144,290	New	+$1.22M	0.03%	379
2020 Q4	–	Sell	-42,305	Closed	-$148K	–	852
2020 Q3	$148K	Buy	+42,305	New	+$201K	0.02%	512

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ergoteles's PGEN Position: Q3 2022 in Review

Ergoteles sold out of Precigen (PGEN) in Q3 2022, closing a stake of 128,000 shares — an estimated $172K sold.

Ergoteles first reported a position in PGEN in Q3 2020 and held it in 5 quarters. The position peaked at $994K in Q1 2021. 165 funds tracked by Wall St. Rank hold PGEN as of Q3 2022.

Ergoteles reported no remaining Precigen position as of Q3 2022 after selling out during the quarter.
Ergoteles sold 128,000 Precigen shares in Q3 2022, an estimated $172K.
Ergoteles first reported a position in Precigen in Q3 2020 and held it in 5 quarters.
Ergoteles's Precigen position peaked at $994K in Q1 2021.
165 funds tracked by Wall St. Rank held Precigen as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.